Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients
Condition: Diabetes Mellitus, Type II Interventions: Drug: Voglibose + Metformin; Drug: Glibenclamide + Metformin Sponsors: University of Zambia; University Teaching Hospital, Lusaka, Zambia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Endocrinology | Fortamet | Heart | Hospitals | Metformin | Research | Zambia Health